|
US4196265A
(en)
*
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
|
US4608337A
(en)
*
|
1980-11-07 |
1986-08-26 |
The Wistar Institute |
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
|
|
US4701409A
(en)
|
1984-11-15 |
1987-10-20 |
The Wistar Institute |
Detection of B-cell neoplasms
|
|
US4693975A
(en)
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
|
US5015568A
(en)
*
|
1986-07-09 |
1991-05-14 |
The Wistar Institute |
Diagnostic methods for detecting lymphomas in humans
|
|
US5202429A
(en)
*
|
1986-07-09 |
1993-04-13 |
The Wistar Institute |
DNA molecules having human BCL-2 gene sequences
|
|
US5198338A
(en)
*
|
1989-05-31 |
1993-03-30 |
Temple University |
Molecular probing for human t-cell leukemia and lymphoma
|
|
US5149628A
(en)
|
1989-11-15 |
1992-09-22 |
Temple University |
Methods for detecting bcl-3 gene in human leukemias
|
|
WO1993012136A1
(en)
*
|
1991-12-11 |
1993-06-24 |
Thomas Jefferson University |
Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
|
|
US6040140A
(en)
*
|
1991-12-11 |
2000-03-21 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
|
US5633135A
(en)
*
|
1991-12-11 |
1997-05-27 |
Thomas Jefferson University |
Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities
|
|
DK0667920T3
(da)
*
|
1992-10-29 |
2003-04-14 |
Univ Jefferson |
Fremgangsmåder til påvisning af prostatacancermetastase
|
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
|
WO1994026930A1
(en)
|
1993-05-14 |
1994-11-24 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
|
US5985598A
(en)
|
1994-10-27 |
1999-11-16 |
Thomas Jefferson University |
TCL-1 gene and protein and related methods and compositions
|
|
US7175995B1
(en)
*
|
1994-10-27 |
2007-02-13 |
Thomas Jefferson University |
TCL-1 protein and related methods
|
|
US5695944A
(en)
|
1995-05-05 |
1997-12-09 |
Thomas Jefferson University |
Modulation of bcl-2 phosphorylation
|
|
US5567586A
(en)
|
1995-05-18 |
1996-10-22 |
Thomas Jefferson University |
Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region
|
|
US5928884A
(en)
*
|
1996-02-09 |
1999-07-27 |
Croce; Carlo M. |
FHIT proteins and nucleic acids and methods based thereon
|
|
US6242212B1
(en)
*
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
WO1998009510A1
(en)
|
1996-09-04 |
1998-03-12 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Methods of diagnosing and treating cancer
|
|
US6187536B1
(en)
|
1997-02-18 |
2001-02-13 |
Thomas Jefferson University |
Methods of identifying and detecting pancreatic cancer
|
|
AU6951098A
(en)
*
|
1997-04-04 |
1998-10-30 |
The Texas A & M University System |
Noninvasive detection of colonic biomarkers using fecal messenger rna
|
|
CA2335315A1
(en)
*
|
1998-07-20 |
2000-01-27 |
Thomas Jefferson University |
Nitrilase homologs
|
|
US6255293B1
(en)
*
|
1998-07-24 |
2001-07-03 |
Yeda Research And Development Co., Ltd. |
Prevention of metastasis with 5-aza-2′-deoxycytidine
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
CA2361396A1
(en)
|
1999-02-25 |
2000-08-31 |
Carlo M. Croce |
Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
|
|
JP2003519463A
(ja)
|
1999-03-15 |
2003-06-24 |
トーマス・ジェファーソン・ユニバーシティー |
ＴＣＬ−１ｂ遺伝子、蛋白質、それらに関連した方法およびそれらに関連する物質
|
|
US6579857B1
(en)
|
1999-06-11 |
2003-06-17 |
Evanston Northwestern Healthcare Research Institute |
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
|
|
US7163801B2
(en)
|
1999-09-01 |
2007-01-16 |
The Burnham Institute |
Methods for determining the prognosis for cancer patients using tucan
|
|
US20040132017A1
(en)
|
1999-12-16 |
2004-07-08 |
Robert Richards |
Oxidoreductase gene associated with the fra16d fragile site
|
|
US6891031B2
(en)
|
2000-02-18 |
2005-05-10 |
The Regents Of The University Of California |
Coordinate cytokine regulatory sequences
|
|
WO2001068666A1
(en)
|
2000-03-14 |
2001-09-20 |
Thomas Jefferson University |
Tcl1 enhances akt kinase activity and mediates its nuclear translocation
|
|
EP1276879A4
(en)
*
|
2000-04-11 |
2004-12-22 |
Univ Jefferson |
MUIR-TORRE-LIKE SYNDROME IN Fhit-DEFECTIVE MICE
|
|
US20020086331A1
(en)
*
|
2000-05-16 |
2002-07-04 |
Carlo Croce |
Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers
|
|
US7060811B2
(en)
*
|
2000-10-13 |
2006-06-13 |
Board Of Regents, The University Of Texas System |
WWOX: a tumor suppressor gene mutated in multiple cancers
|
|
WO2002064171A1
(en)
|
2001-02-12 |
2002-08-22 |
Thomas Jefferson University |
Adenoviral transduction of fragile histidine triad (fhit) into cancer cells
|
|
WO2002064172A2
(en)
|
2001-02-12 |
2002-08-22 |
Thomas Jefferson University |
Fhit gene therapy prevents tumor development in fhit-deficient mice
|
|
US20040033502A1
(en)
*
|
2001-03-28 |
2004-02-19 |
Amanda Williams |
Gene expression profiles in esophageal tissue
|
|
US20050176025A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
|
|
JP4371812B2
(ja)
|
2001-09-28 |
2009-11-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
マイクロｒｎａ分子
|
|
US7371736B2
(en)
*
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
|
GB0128898D0
(en)
*
|
2001-12-03 |
2002-01-23 |
Biotech Res Ventures Pte Ltd |
Materials and methods relating to the stabilization and activation of a tumour suppressor protein
|
|
WO2003076424A1
(en)
|
2002-03-08 |
2003-09-18 |
Eisai Co. Ltd. |
Macrocyclic compounds useful as pharmaceuticals
|
|
DK3115470T3
(en)
|
2002-03-13 |
2018-11-05 |
Genomic Health Inc |
Gene Expression Profiling in Tumor Tissue Biopsies
|
|
WO2003086445A1
(en)
*
|
2002-04-08 |
2003-10-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in hepatocellular carcinoma
|
|
WO2003092370A1
(en)
|
2002-04-29 |
2003-11-13 |
Thomas Jefferson University |
Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
|
|
EP1530418A4
(en)
*
|
2002-05-31 |
2005-10-12 |
Univ Leland Stanford Junior |
METHOD FOR IDENTIFYING AND INSULATING STEM CELLS AND CANCER STAMPS
|
|
US20050260639A1
(en)
|
2002-09-30 |
2005-11-24 |
Oncotherapy Science, Inc. |
Method for diagnosing pancreatic cancer
|
|
EP1581621A4
(en)
*
|
2002-10-11 |
2006-07-05 |
Univ Jefferson |
NEW TUMORSUPPRESSORGEN AND COMPOSITIONS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
US20050266443A1
(en)
|
2002-10-11 |
2005-12-01 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
CA2504605C
(en)
*
|
2002-11-13 |
2016-01-19 |
Thomas Jefferson University |
Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
WO2004071464A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
WO2004079013A1
(en)
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
|
|
US7183384B2
(en)
|
2003-03-06 |
2007-02-27 |
A & G Pharmaceutical, Inc. |
Monoclonal antibody 7H11 reactive with human cancer
|
|
AU2003286741A1
(en)
|
2003-05-02 |
2004-11-26 |
Thomas Jefferson University |
Methods and compositions for diagnosis and therapy of parkin-associated disorders
|
|
US20050069918A1
(en)
*
|
2003-05-29 |
2005-03-31 |
Francois Claret |
JAB1 as a prognostic marker and a therapeutic target for human cancer
|
|
RU2376371C2
(ru)
|
2003-06-18 |
2009-12-20 |
Дженелюкс Корпорейшн |
Модифицированные рекомбинантные вакцинирующие вирусы и другие микроорганизмы и их применение
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
US20050037362A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Eppendorf Array Technologies, S.A. |
Detection and quantification of siRNA on microarrays
|
|
US8412541B2
(en)
|
2003-08-14 |
2013-04-02 |
Edda Technology, Inc. |
Method and system for intelligent qualitative and quantitative analysis for medical diagnosis
|
|
WO2005020795A2
(en)
|
2003-08-25 |
2005-03-10 |
The Johns Hopkins University |
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differntial gene expression analysis
|
|
CA2539651A1
(en)
*
|
2003-09-22 |
2005-04-07 |
Rosetta Inpharmatics Llc |
Synthetic lethal screen using rna interference
|
|
JP2007506425A
(ja)
*
|
2003-09-24 |
2007-03-22 |
オンコセラピー・サイエンス株式会社 |
肝細胞癌を診断する方法
|
|
WO2005047477A2
(en)
*
|
2003-11-07 |
2005-05-26 |
University Of Massachusetts |
Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
|
|
US20050164252A1
(en)
|
2003-12-04 |
2005-07-28 |
Yeung Wah Hin A. |
Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
|
|
DE602004031881D1
(de)
|
2003-12-19 |
2011-04-28 |
Univ California |
Verfahren und materialien zur beurteilung von prostatakrebstherapien
|
|
WO2005078096A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
WO2005078139A2
(en)
|
2004-02-09 |
2005-08-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
WO2005079397A2
(en)
*
|
2004-02-13 |
2005-09-01 |
Rockefeller University |
Anti-microrna oligonucleotide molecules
|
|
AU2005214286A1
(en)
|
2004-02-23 |
2005-09-01 |
Erasmus University Medical Center Rotterdam |
Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
|
|
US7365058B2
(en)
|
2004-04-13 |
2008-04-29 |
The Rockefeller University |
MicroRNA and methods for inhibiting same
|
|
EP1745150A4
(en)
|
2004-04-20 |
2008-02-27 |
Genaco Biomedial Products Inc |
METHOD FOR DETECTING NCRNA
|
|
EP2322650A1
(en)
*
|
2004-05-14 |
2011-05-18 |
Rosetta Genomics Ltd |
MicroRNAs and uses thereof
|
|
EP2290072B1
(en)
|
2004-05-28 |
2014-12-17 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
*
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
US20060037088A1
(en)
*
|
2004-08-13 |
2006-02-16 |
Shulin Li |
Gene expression levels as predictors of chemoradiation response of cancer
|
|
JP2008511678A
(ja)
|
2004-09-02 |
2008-04-17 |
イェール ユニバーシティ |
マイクロｒｎａによるオンコジーンの調節
|
|
US7642348B2
(en)
*
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
|
FR2877350B1
(fr)
*
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
|
ES2534304T3
(es)
*
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
ATE544774T1
(de)
*
|
2004-12-14 |
2012-02-15 |
Alnylam Pharmaceuticals Inc |
Rnai-modulation von mll-af4 und verwendungen dafür
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
US20070099196A1
(en)
*
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
|
DE602006016739D1
(de)
*
|
2005-01-25 |
2010-10-21 |
Rosetta Inpharmatics Llc |
Verfahren zur quantifizierung kleiner rna-moleküle
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
US20070065840A1
(en)
*
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
GB2425311A
(en)
|
2005-04-15 |
2006-10-25 |
Ist Superiore Sanita |
Micro RNA against kit protein
|
|
CA2605701C
(en)
|
2005-04-29 |
2015-12-08 |
Rockefeller University |
Human micrornas and methods for inhibiting same
|
|
WO2006133022A2
(en)
|
2005-06-03 |
2006-12-14 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
US20070065844A1
(en)
*
|
2005-06-08 |
2007-03-22 |
Massachusetts Institute Of Technology |
Solution-based methods for RNA expression profiling
|
|
US20060292616A1
(en)
|
2005-06-23 |
2006-12-28 |
U.S. Genomics, Inc. |
Single molecule miRNA-based disease diagnostic methods
|
|
CN101341259B
(zh)
*
|
2005-08-01 |
2011-12-21 |
俄亥俄州立大学研究基金会 |
用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
WO2007021896A2
(en)
*
|
2005-08-10 |
2007-02-22 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
|
|
EP1937280B1
(en)
|
2005-09-12 |
2014-08-27 |
The Ohio State University Research Foundation |
Compositions for the therapy of bcl2-associated cancers
|
|
CA2624531A1
(en)
|
2005-10-05 |
2007-04-19 |
Carlo M. Croce |
Wwox gene, vectors containing the same, and uses in treatment of cancer
|
|
US7390792B2
(en)
*
|
2005-12-15 |
2008-06-24 |
Board Of Regents, The University Of Texas System |
MicroRNA1 therapies
|
|
ES2429404T3
(es)
|
2006-01-05 |
2013-11-14 |
The Ohio State University Research Foundation |
Procedimientos basados en los microARN para el diagnóstico y el pronóstico del cáncer de pulmón
|
|
JP5490413B2
(ja)
|
2006-01-05 |
2014-05-14 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロｒｎａ発現異常
|
|
EP2487261B1
(en)
|
2006-01-05 |
2015-07-01 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
WO2007084485A2
(en)
|
2006-01-13 |
2007-07-26 |
Battelle Memorial Institute |
Markers for assessing copd-related diseases
|
|
CA2646051A1
(en)
|
2006-03-20 |
2007-09-27 |
Carlo M. Croce |
Microrna fingerprints during human megakaryocytopoiesis
|
|
WO2007112097A2
(en)
|
2006-03-24 |
2007-10-04 |
Children's Medical Center Corporation |
Novel signature self renewal gene expression programs
|
|
ES2715625T3
(es)
*
|
2006-04-03 |
2019-06-05 |
Roche Innovation Ct Copenhagen As |
Composición farmacéutica que comprende oligonucleótidos antisentido anti-miARN
|
|
JP5127821B2
(ja)
|
2006-04-24 |
2013-01-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ｍｉＲ１５５トランスジェニックマウスにおけるプレＢ細胞増殖及びリンパ芽球性白血病／高悪性度リンパ腫
|
|
WO2008008430A2
(en)
|
2006-07-13 |
2008-01-17 |
The Ohio State University Research Foundation |
Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
|
|
EA016145B1
(ru)
|
2006-08-30 |
2012-02-28 |
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган |
Новые низкомолекулярные ингибиторы mdm2 и их применение
|
|
US20080193943A1
(en)
|
2006-09-05 |
2008-08-14 |
Abbott Laboratories |
Companion diagnostic assays for cancer therapy
|
|
EP2145001A2
(en)
|
2006-09-19 |
2010-01-20 |
Asuragen, Inc. |
Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
|
US8071292B2
(en)
*
|
2006-09-19 |
2011-12-06 |
The Ohio State University Research Foundation |
Leukemia diagnostic methods
|
|
WO2008036765A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
EP2076599A2
(en)
*
|
2006-09-19 |
2009-07-08 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
|
JP2008086201A
(ja)
*
|
2006-09-29 |
2008-04-17 |
Gifu Prefecture Kenkyu Kaihatsu Zaidan |
マイクロｒｎａ生成の検出方法と癌の診断・治療およびマイクロｒｎａ生成調整剤
|
|
EP2087135B8
(en)
|
2006-11-01 |
2013-07-24 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
|
CN101622350A
(zh)
*
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为干预治疗靶标的miR-126调控基因和通路
|
|
CA2671194A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
DK2104737T3
(da)
*
|
2006-12-08 |
2013-05-27 |
Asuragen Inc |
Funktioner og formål for let-7 mikro-RNAer
|
|
WO2008073920A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-21 regulated genes and pathways as targets for therapeutic intervention
|
|
US20090175827A1
(en)
*
|
2006-12-29 |
2009-07-09 |
Byrom Mike W |
miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
CN103555825B
(zh)
|
2007-01-31 |
2015-09-30 |
俄亥俄州立大学研究基金会 |
用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物
|
|
US7601399B2
(en)
*
|
2007-01-31 |
2009-10-13 |
Surface Modification Systems, Inc. |
High density low pressure plasma sprayed focal tracks for X-ray anodes
|
|
EP2126078B2
(en)
|
2007-02-27 |
2023-01-04 |
Rosetta Genomics Ltd |
Composition and methods for modulating cell proliferation and cell death
|
|
EP2126584B1
(en)
|
2007-03-16 |
2012-12-19 |
CovalX AG |
Direct mass spectrometric analysis of drug candidates targeting protein complexes
|
|
WO2008124777A1
(en)
|
2007-04-10 |
2008-10-16 |
National Taiwan University |
Predicting post-treatment survival in cancer patients with micrornas
|
|
WO2008136971A1
(en)
|
2007-04-30 |
2008-11-13 |
The Ohio State University Research Foundation |
Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
|
|
US20090005336A1
(en)
*
|
2007-05-08 |
2009-01-01 |
Zhiguo Wang |
Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
|
|
US20090131354A1
(en)
*
|
2007-05-22 |
2009-05-21 |
Bader Andreas G |
miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US20090232893A1
(en)
|
2007-05-22 |
2009-09-17 |
Bader Andreas G |
miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
WO2008154098A2
(en)
*
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
US20090227533A1
(en)
|
2007-06-08 |
2009-09-10 |
Bader Andreas G |
miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention
|
|
ES2527648T3
(es)
|
2007-06-08 |
2015-01-28 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para determinar el subtipo de carcinoma hepatocelular
|
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
|
CA2695184A1
(en)
|
2007-07-31 |
2009-02-05 |
The Ohio State University Research Foundation |
Methods for reverting methylation by targeting dnmt3a and dnmt3b
|
|
ES2570359T3
(es)
*
|
2007-08-03 |
2016-05-18 |
Univ Ohio State Res Found |
Regiones ultraconservadas que codifican ARNnc
|
|
EP3028708A1
(en)
|
2007-08-22 |
2016-06-08 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
|
US20090061424A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Sigma-Aldrich Company |
Universal ligation array for analyzing gene expression or genomic variations
|
|
AU2008296022B2
(en)
|
2007-09-06 |
2014-01-23 |
The Ohio State University Research Foundation |
MicroRNA signatures in human ovarian cancer
|
|
JP5624470B2
(ja)
*
|
2007-09-14 |
2014-11-12 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションＴｈｅ Ｏｈｉｏ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
ヒト末梢血微小胞におけるｍｉＲＮＡの発現およびその使用
|
|
CA2702241A1
(en)
|
2007-10-11 |
2009-04-16 |
The Ohio State University Research Foundation |
Methods and compositions for the diagnosis and treatment of esophageal adenocarcinomas
|
|
JP2011504093A
(ja)
|
2007-10-26 |
2011-02-03 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
脆弱性ヒスチジン三連構造（ｆｈｉｔ）相互作用を同定するための方法およびその使用
|
|
EP2217706B1
(en)
|
2007-11-12 |
2015-05-27 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
|
US20090123933A1
(en)
*
|
2007-11-12 |
2009-05-14 |
Wake Forest University Health Sciences |
Microrna biomarkers in lupus
|
|
US20100323357A1
(en)
|
2007-11-30 |
2010-12-23 |
The Ohio State University Research Foundation |
MicroRNA Expression Profiling and Targeting in Peripheral Blood in Lung Cancer
|
|
US8071562B2
(en)
*
|
2007-12-01 |
2011-12-06 |
Mirna Therapeutics, Inc. |
MiR-124 regulated genes and pathways as targets for therapeutic intervention
|
|
US20090192114A1
(en)
*
|
2007-12-21 |
2009-07-30 |
Dmitriy Ovcharenko |
miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention
|
|
CN105734128B
(zh)
|
2008-02-01 |
2021-05-18 |
总医院有限公司 |
微泡在医学疾病和病况的诊断、预后以及治疗中的用途
|
|
WO2009100430A2
(en)
|
2008-02-08 |
2009-08-13 |
Asuragen, Inc |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
AU2009219203B2
(en)
|
2008-02-28 |
2014-04-03 |
The Ohio State University Research Foundation |
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia (AML) and uses thereof
|
|
EP2260109A4
(en)
|
2008-02-28 |
2011-06-08 |
Univ Ohio State Res Found |
MICRORNA BASED METHOD AND COMPOSITIONS FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES RELATED TO THE PROSTATE
|
|
EP2254668A4
(en)
|
2008-02-28 |
2012-08-15 |
Univ Ohio State Res Found |
MICROARN SIGNATURES ASSOCIATED WITH HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND USES THEREOF
|
|
EP3064584A3
(en)
|
2008-02-28 |
2016-12-07 |
The Ohio State University Research Foundation |
Micro rna-based methods and compositions for the diagnosis, prognosis and treatmentof gastric cancer
|
|
US20090233297A1
(en)
|
2008-03-06 |
2009-09-17 |
Elizabeth Mambo |
Microrna markers for recurrence of colorectal cancer
|
|
EP2271757A2
(en)
|
2008-03-26 |
2011-01-12 |
Asuragen, INC. |
Compositions and methods related to mir-16 and therapy of prostate cancer
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
US8900627B2
(en)
|
2008-06-06 |
2014-12-02 |
Mirna Therapeutics, Inc. |
Compositions for the in vivo delivery of RNAi agents
|
|
CN102149827B
(zh)
|
2008-06-11 |
2014-08-20 |
由卫生与公众服务部代表的美利坚合众国政府 |
MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途
|
|
CN102149401A
(zh)
|
2008-08-12 |
2011-08-10 |
俄亥俄州立大学研究基金会 |
用于多发性骨髓瘤的诊断、预后和治疗的基于微rna的组合物和方法
|
|
WO2010059779A1
(en)
|
2008-11-21 |
2010-05-27 |
The Ohio State University Research Foundation |
Tcl1 AS A TRANSCRIPTIONAL REGULATOR
|
|
US20110275534A1
(en)
|
2008-12-05 |
2011-11-10 |
The Ohio State University |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
|
|
WO2010099161A1
(en)
|
2009-02-26 |
2010-09-02 |
The Ohio State University Research Foundation |
Micrornas in never-smokers and related materials and methods
|